Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain
暂无分享,去创建一个
Q. Bassat | E. Gratacós | D. Cuadras | E. Bonet-Carne | M. Morales | D. Henares | P. Brotons | C. Launes | C. Muñoz-Almagro | I. Jordan | F. Perez-Soler | C. Fortuny | J. García-García | L. Alsina | C. Jou | I. Uribesalgo | J. Claverol | M. Ríos | Laura Fuente-Soro | V. Fumadó | Núria Balanza | R. Varo | Pere Millat | B. Baro | S. Ajanovic | Sara Arias | M. Cubells | Francesc Torrents | A. Valls | M. Mele | M. de Sevilla | Gemma Pons | A. Redin | Elena Buetas | Cristina Adroher | Cristina Laia Sara Ainhoa Sara Nuria Barbara Elisenda Joana Adroher Alsina Ajanovic Andueza Arias Ba | Ainhoa Andueza | Aleix Garcia-Miguel | Maria Hernandez | V. Fumado | Pere Millat | S. Arias
[1] Rinshu Dwivedi,et al. The incubation period of coronavirus disease (COVID‐19): A tremendous public health threat—Forecasting from publicly available case data in India , 2021, Journal of public affairs.
[2] Jianyun Lu,et al. COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020 , 2020, Emerging infectious diseases.
[3] Mark S. Anderson,et al. Test performance evaluation of SARS-CoV-2 serological assays , 2020, Nature biotechnology.
[4] Young Joon Park,et al. Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020 , 2020, Emerging infectious diseases.
[5] M. Hernán,et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.
[6] X. Tang,et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.
[7] L. Fang,et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.
[8] F. Zhou,et al. Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan -implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2 , 2020, medRxiv.
[9] P. Horby,et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study , 2020, BMJ.
[10] Ying-jian Liang,et al. Household Transmission of SARS-CoV-2, Zhuhai, China, 2020 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] David R. Holtgrave,et al. COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State—March 2020 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Hsien-Ho Lin,et al. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset , 2020, JAMA internal medicine.
[13] H. Tian,et al. Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China , 2020, BMJ Global Health.
[14] Mark S. Anderson,et al. Test performance evaluation of SARS-CoV-2 serological assays , 2020, medRxiv.
[15] A. Vespignani,et al. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China , 2020, Science.
[16] Yongsheng Wu,et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.
[17] K. Tao,et al. The characteristics of household transmission of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Kari Stefansson,et al. Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.
[19] Gang Wu,et al. Household transmission of SARS-CoV-2 , 2020, Journal of Infection.
[20] T. Skoff,et al. Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[21] A. Tagarro,et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. , 2020, JAMA pediatrics.
[22] Lauren Elisabeth Steele,et al. Children are unlikely to have been the primary source of household SARS-CoV-2 infections , 2020, medRxiv.
[23] Qi Jin,et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Zhongyi Jiang,et al. Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.
[25] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[26] Yhu-Chering Huang,et al. Are children less susceptible to COVID-19? , 2020, Journal of Microbiology, Immunology and Infection.
[27] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[28] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[29] T. Burki. Coronavirus in China , 2020, The Lancet Respiratory Medicine.
[30] Don Klinkenberg,et al. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[31] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[32] W. Cao,et al. Disappearance of antibodies to SARS-associated coronavirus after recovery. , 2007, The New England journal of medicine.
[33] World Health Organization,et al. Transmission of SARS-CoV-2: implications for infection prevention precautions , 2020 .